Cellectis Beta
¿Qué es el Beta de Cellectis?
El Beta de Cellectis es 2.35
¿Cuál es la definición de Beta?
BETA indica si una acción es más o menos volátil que el mercado en su conjunto. Una beta inferior a 1 indica que el stock es menos volátil que el mercado, mientras que una beta más de 1 indica que el stock es más volátil. La volatilidad se mide como la fluctuación del precio alrededor de la media.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta de compañías en Sector Health Care en NASDAQ en comparadas con Cellectis
¿Qué hace Cellectis?
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.
Empresas con beta similar a Cellectis
- High Arctic Services tiene Beta de 2.34
- Forza Petroleum tiene Beta de 2.35
- GreenPower Motor Co tiene Beta de 2.35
- Telix Pharmaceuticals tiene Beta de 2.35
- Endurance Gold tiene Beta de 2.35
- Dwarikesh Sugar Industries tiene Beta de 2.35
- Cellectis tiene Beta de 2.35
- Spitfire Oil tiene Beta de 2.35
- Valterra Resource tiene Beta de 2.35
- Copper Road Resources Inc tiene Beta de 2.35
- Shopify Inc tiene Beta de 2.35
- Cann American tiene Beta de 2.35
- Satori Resources tiene Beta de 2.35